Celltrion | 068270 - Operating Expenses

Stock Price
195,800.00
Daily Change
500.00 0.26%
Monthly
-4.02%
Yearly
19.10%
Q2 Forecast
184,597.56

Celltrion reported KRW724.99B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Celltrion KRW 724.99B 6B Sep/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025